4.6 Article

TREM2 mediates MHCII-associated CD4+ T-cell response against gliomas

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Multidisciplinary Sciences

CD4+ T cell-induced inflammatory cell death controls immune-evasive tumours

Bastian Kruse et al.

Summary: Most clinically applied cancer immunotherapies rely on direct recognition and killing of tumor cells by CD8(+) cytolytic T cells. However, the effectiveness of these strategies is limited by the emergence of MHC-deficient tumor cells and immunosuppressive tumor microenvironment. In this study, researchers have discovered that a small number of CD4(+) T cells can eliminate MHC-deficient tumors that escape CD8(+) T cell targeting. CD4(+) effector T cells cluster at tumor invasive margins and interact with MHC-II(+)CD11c(+) antigen-presenting cells, leading to the activation of tumoricidal myeloid cells. Together, CD4(+) T cells and tumoricidal myeloid cells induce inflammatory cell death and eradicate interferon-unresponsive and MHC-deficient tumors, suggesting a potential strategy to complement current cancer immunotherapies.

NATURE (2023)

Article Multidisciplinary Sciences

TREM2 inhibition triggers antitumor cell activity of myeloid cells in glioblastoma

Rui Sun et al.

Summary: This study found that TREM2 is highly expressed in myeloid subsets in human and mouse GBM tumors and is associated with poor prognosis. Loss of TREM2 function leads to increased immunoactivation, proinflammatory polarization, and tumoricidal capacity in myeloid cells. Inhibition of TREM2 reprograms myeloid phenotypes and enhances the effectiveness of anti-PD-1 treatment in GBM.

SCIENCE ADVANCES (2023)

Article Oncology

MHC class II-restricted antigen presentation is required to prevent dysfunction of cytotoxic T cells by blood-borne myeloids in brain tumors

Michael Kilian et al.

Summary: Cancer immunotherapy relies on the fitness of cytotoxic and helper T cell responses. Dysfunctional cytotoxic T cell states in the tumor microenvironment (TME) are a main cause of resistance to immuno-therapy. Intratumoral myeloid cells, especially blood-borne myeloids (bbm), drive T cell dysfunction in the TME. This study demonstrates that major histocompatibility complex class II (MHCII)-restricted antigen presentation on bbm is crucial for controlling brain tumor growth.

CANCER CELL (2023)

Article Immunology

CTLA-4 blockade induces a microglia-Th1 cell partnership that stimulates microglia phagocytosis and anti-tumor function in glioblastoma

Dan Chen et al.

Summary: This study highlights the potential of CTLA-4 blockade in prolonging survival in mesenchymal-like glioblastoma mouse models by promoting a CD4+ T cell-microglia circuit involving IFNy-mediated microglia activation and phagocytosis. CD4+ T cells interact directly with microglia, triggering their activation and tumor suppression through AXL/MER tyrosine kinase receptors.

IMMUNITY (2023)

Review Oncology

CD4+ T cells in cancer

Daniel. E. Speiser et al.

Summary: Speiser and colleagues provide an overview of recent advances in understanding the biological roles of CD4(+) T cells in cancer immunology and their applications in immunotherapy. While most research in oncology has focused on CD8(+) T cells and the tumor microenvironment, recent progress has highlighted the importance of CD4(+) T cells as central players in innate and antigen-specific immune responses. Furthermore, they have been recognized as potent anti-tumor effector cells. This review summarizes the current state of CD4(+) T cells in cancer and their potential for improving cancer knowledge and therapies.

NATURE CANCER (2023)

Review Oncology

T follicular helper cells in cancer

Nicolas Gutierrez-Melo et al.

Summary: T follicular helper (Tfh) cells play a crucial role in aiding B cells in antibody-mediated immune responses. While their importance in infection and vaccination is well-established, their involvement in cancer is only starting to be understood. The presence of increased numbers of Tfh cells in Tfh cell-derived or B cell-associated malignancies is often linked to poor prognosis, whereas their presence in non-lymphocytic solid organ tumors is associated with better outcomes. Recent advances have shed light on how the interaction between Tfh cells, B cells, and CD8+ T cells in lymphoid structures enhances antitumor immunity, but also how it may lead to immune-related adverse events (irAEs) such as autoimmunity during immune checkpoint blockade (ICB) and cancer immunotherapy.

TRENDS IN CANCER (2023)

Review Immunology

The biology of TREM receptors

Marco Colonna

Summary: In this comprehensive review, Marco Colonna summarizes the structure, ligands, signaling modes, and functions of TREMs in both humans and mice. TREMs play a crucial role in modulating signaling in myeloid cells and have been implicated in various diseases such as inflammatory diseases, autoimmunity, neurodegeneration, and cancer.

NATURE REVIEWS IMMUNOLOGY (2023)

Review Developmental Biology

Microglial TREM2 in amyotrophic lateral sclerosis

Manling Xie et al.

Summary: ALS, a motor neuron degenerative disease, involves the activation of glial cells, particularly microglia, with a focus on the role of the surface receptor TREM2. Understanding the function of TREM2 in ALS pathogenesis can help identify potential molecular targets for treatment.

DEVELOPMENTAL NEUROBIOLOGY (2022)

Article Neurosciences

TREM2 interacts with TDP-43 and mediates microglial neuroprotection against TDP-43-related neurodegeneration

Manling Xie et al.

Summary: The study reveals that TREM2 plays a crucial role in TDP-43-related neurodegeneration, with TREM2 deficiency exacerbating neuronal damage and motor impairments. Mass cytometry analysis and surface plasmon resonance analysis demonstrate the interaction between TDP-43 and TREM2.

NATURE NEUROSCIENCE (2022)

Article Clinical Neurology

Syngeneic murine glioblastoma models: reactionary immune changes and immunotherapy intervention outcomes

Vijay Letchuman et al.

Summary: The choice of the appropriate syngeneic murine model is critical for immunotherapy research on glioblastoma as it can impact the translatability of the results from mouse to human trials.

NEUROSURGICAL FOCUS (2022)

Article Oncology

Immunosuppressive TREM2(+) macrophages are associated with undesirable prognosis and responses to anti-PD-1 immunotherapy in non-small cell lung cancer

Hongyu Zhang et al.

Summary: This study reveals the presence of a TAM subtype associated with immunotherapy response in non-small cell lung cancer (NSCLC), specifically, the TREM2 positive TAMs. NSCLC patients with high infiltration of TREM2(+) TAMs show advanced tumor progression and poor prognosis, as well as unique molecular characteristics. Low TREM2(+) TAMs predict higher response rates to PD-1-based immunotherapy.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2022)

Article Oncology

Lipid-Associated Macrophages Are Induced by Cancer-Associated Fibroblasts and Mediate Immune Suppression in Breast Cancer

Eleonora Timperi et al.

Summary: This study identifies a novel lipid-associated macrophage subpopulation with immune suppressive functions and provides new leads for therapeutic interventions in triple-negative breast cancer.

CANCER RESEARCH (2022)

Article Immunology

TREM2 macrophages induced by human lipids drive inflammation in acne lesions

Tran H. Do et al.

Summary: Acne, a common skin condition affecting 1 in 10 people globally, is characterized by disfiguring facial lesions. This study explored the mechanisms underlying the disease using single-cell and spatial RNA sequencing, as well as ultrahigh-resolution Seq-Scope analysis. The researchers identified TREM2 macrophages expressing lipid metabolism and proinflammatory genes near the hair follicle epithelium, which expressed squalene epoxidase. Through in vitro experiments, it was discovered that squalene induced differentiation of TREM2 macrophages, impairing their ability to kill Cutibacterium acnes. Additionally, the addition of squalene to macrophages inhibited oxidative enzymes and scavenged oxygen free radicals, providing insights into the efficacy of benzoyl peroxide in acne treatment. These findings contribute to our understanding of the role of TREM2 macrophages and unsaturated lipids in the pathogenesis of acne, as well as their similarity to atherosclerosis.

SCIENCE IMMUNOLOGY (2022)

Article Medicine, Research & Experimental

PD-1 and ICOS coexpression identifies tumor-reactive CD4+ T cells in human solid tumors

Rebekka Duhen et al.

Summary: CD4(+) Th cells have been shown to play a critical role in antitumor immune response. In this study, a subset of CD4(+) Th cells co-expressing PD-1 and ICOS was identified in head and neck squamous cell carcinoma and colorectal cancers. These cells had a tissue-resident memory phenotype, proliferated in the tumor, and recognized both tumor-associated antigens and tumor-specific neoantigens.

JOURNAL OF CLINICAL INVESTIGATION (2022)

Article Immunology

TREM2 macrophages induced by human lipids drive inflammation in acne lesions

Tran H. Do et al.

Summary: This study elucidated the role of TREM2 macrophages and unsaturated lipids in the pathogenesis of acne, providing a new theoretical basis for the treatment of acne.

SCIENCE IMMUNOLOGY (2022)

Review Biotechnology & Applied Microbiology

PD-1/PD-L1 immune checkpoint inhibitors in glioblastoma: clinical studies, challenges and potential

Tianrui Yang et al.

Summary: Immune checkpoint inhibitors have revolutionized tumor immunotherapy, but face challenges in the treatment of glioblastoma due to its unique immunosuppressive characteristics. Recent clinical studies are focusing on combination therapies involving standard treatments, targeted therapies, and other immunotherapies to improve outcomes for patients with GBM.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)

Article Medicine, Research & Experimental

Protein tyrosine phosphatase nonreceptortype 2 controls colorectal cancer development

Egle Katkeviciute et al.

Summary: PTPN2 has emerged as a potential target for cancer immunotherapy, with increased expression correlating with disease progression and decreased immune responses in human colorectal carcinoma. Deletion of T cell-specific PTPN2 reduces tumor burden and enhances antitumor immunity in CRC models, suggesting it could be exploited for cancer immunotherapy.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Article Biotechnology & Applied Microbiology

B16 melanoma control by anti-PD-L1 requires CD8+T cells and NK cells: application of anti-PD-L1 Abs and Trp2 peptide vaccines

Sunhee Ji et al.

Summary: Studies have shown that the effectiveness of anti-PD-L1 therapy in controlling different types of tumors may be related to the infiltration status of CD8 + T cells in tumor tissues. In the B16 model, anti-PD-L1 therapy controls tumor growth by activating CD8 + T cells and NK cells.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)

Article Cell Biology

Targeting TREM2 on tumor-associated macrophages enhances immunotherapy

Mikhail Binnewies et al.

Summary: Research has identified a correlation between TREM2(+) tumor-associated macrophages (TAMs) and exhausted CD8(+) tumor-infiltrating lymphocytes (TILs), with therapy targeting TREM2 showing potential in promoting anti-tumor immunity.

CELL REPORTS (2021)

Article Multidisciplinary Sciences

TREM-2 is a sensor and activator of T cell response in SARS-CoV-2 infection

Yongjian Wu et al.

Summary: Limited understanding of T cell responses against SARS-CoV-2 has hindered vaccine development and drug discovery for COVID-19. This study reveals an previously unknown role for TREM-2 in SARS-CoV-2 infection, suggesting potential strategies for drug discovery and clinical management of COVID-19.

SCIENCE ADVANCES (2021)

Article Neurosciences

Single-cell profiling of myeloid cells in glioblastoma across species and disease stage reveals macrophage competition and specialization

Ana Rita Pombo Antunes et al.

Summary: By utilizing single-cell RNA sequencing and CITE-seq, this study reveals the complexity of the immune landscape in glioblastomas, including conserved populations of dendritic cells and macrophages. The results indicate that microglia-derived tumor-associated macrophages dominate in newly diagnosed tumors, but are replaced by monocyte-derived TAMs in recurrences.

NATURE NEUROSCIENCE (2021)

Article Biochemistry & Molecular Biology

Integrated analysis of multimodal single-cell data

Yuhan Hao et al.

Summary: The study introduces a weighted-nearest neighbor analysis framework to learn the relative utility of each data type in each cell, enabling integrative analysis of multiple modalities. Applied to a CITE-seq dataset, the method constructs a multimodal reference atlas of the circulating immune system and successfully identifies and validates previously unreported lymphoid subpopulations.
Review Immunology

CD4+T cells that help B cells - a proposal for uniform nomenclature

Stephanie C. Eisenbarth et al.

Summary: Tfh and Tfh-like cells guide B cell differentiation in secondary lymphoid tissues, playing essential roles in humoral immunity. They produce diverse combinations of cytokines and chemokine receptors to promote the generation of antibodies with different properties.

TRENDS IN IMMUNOLOGY (2021)

Article Multidisciplinary Sciences

Interpretation of T cell states from single-cell transcriptomics data using reference atlases

Massimo Andreatta et al.

Summary: The authors successfully established reference T cell atlases for cancer and viral infection by integrating multiple studies and developing ProjecTILs algorithm. It accurately predicts cell perturbations effects and identifies highly conserved T cell subtypes, providing a stable basis for describing T cell heterogeneity consistently across different diseases and species.

NATURE COMMUNICATIONS (2021)

Article Medicine, Research & Experimental

TREM-2 promotes Th1 responses by interacting with the CD3ζ-ZAP70 complex following Mycobacterium tuberculosis infection

Yongjian Wu et al.

Summary: TREM-2 is induced on CD4(+) T cells in response to Mycobacterium tuberculosis infection and plays a critical role in promoting proinflammatory Th1 responses for host defense. The study reveals a potential therapeutic target for infectious and inflammatory diseases by targeting TREM-2.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Article Oncology

Pharmacological inhibition of BACE1 suppresses glioblastoma growth by stimulating macrophage phagocytosis of tumor cells

Kui Zhail et al.

Summary: The study identified brain-penetrant BACE1 inhibitors as regulators of macrophage-dependent phagocytosis in glioblastoma through IL-6-STAT3 signaling. Utilizing MK-8931 to reprogram pTAMs into sTAMs and promote macrophage phagocytosis, in combination with low-dose radiation, shows promising therapeutic efficacy in suppressing malignant growth in preclinical models. These findings suggest a potential streamline of BACE1 inhibitors for cancer therapy, offering a new approach to enhance macrophage-based therapy for malignant tumors.

NATURE CANCER (2021)

Article Cell Biology

Gliomas Interact with Non-glioma Brain Cells via Extracellular Vesicles

Xiaofei Gao et al.

CELL REPORTS (2020)

Article Biochemistry & Molecular Biology

Local externalization of phosphatidylserine mediates developmental synaptic pruning by microglia

Nicole Scott-Hewitt et al.

EMBO JOURNAL (2020)

Article Biochemistry & Molecular Biology

Coupled scRNA-Seq and Intracellular Protein Activity Reveal an Immunosuppressive Role of TREM2 in Cancer

Yonatan Katzenelenbogen et al.

Article Biochemistry & Molecular Biology

TREM2 Modulation Remodels the Tumor Myeloid Landscape Enhancing Anti-PD-1 Immunotherapy

Martina Molgora et al.

Article Multidisciplinary Sciences

MHC-II neoantigens shape tumour immunity and response to immunotherapy

Elise Alspach et al.

NATURE (2019)

Article Biochemical Research Methods

Fast, sensitive and accurate integration of single-cell data with Harmony

Ilya Korsunsky et al.

NATURE METHODS (2019)

Article Medicine, Research & Experimental

Tertiary lymphoid structures in the choroid plexus in neuropsychiatric lupus

Ariel D. Stock et al.

JCI INSIGHT (2019)

Review Clinical Neurology

TREM2-a key player in microglial biology and Alzheimer disease

Tyler K. Ulland et al.

NATURE REVIEWS NEUROLOGY (2018)

Article Medicine, Research & Experimental

Age-related tumor growth in mice is related to integrin alpha 4 in CD8(+) T cells

Juhyun Oh et al.

JCI INSIGHT (2018)

Article Biochemistry & Molecular Biology

GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses

Zefang Tang et al.

NUCLEIC ACIDS RESEARCH (2017)

Article Multidisciplinary Sciences

Targeted two-photon chemical apoptotic ablation of defined cell types in vivo

Robert A. Hill et al.

NATURE COMMUNICATIONS (2017)

Article Immunology

TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques

Yaming Wang et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2016)

Article Biochemical Research Methods

Superior isolation of antigen-specific brain infiltrating T cells using manual homogenization technique

Luz M. Cumba Garcia et al.

JOURNAL OF IMMUNOLOGICAL METHODS (2016)

Article Neurosciences

TREM2 variants: new keys to decipher Alzheimer disease pathogenesis

Marco Colonna et al.

NATURE REVIEWS NEUROSCIENCE (2016)

Article Clinical Neurology

TREM2 regulates microglial cell activation in response to demyelination in vivo

Claudia Cantoni et al.

ACTA NEUROPATHOLOGICA (2015)

Article Biochemistry & Molecular Biology

TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer's Disease Model

Yaming Wang et al.

Article Biochemistry & Molecular Biology

Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2)

Yuka Atagi et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2015)

Article Multidisciplinary Sciences

PD-1 blockade induces responses by inhibiting adaptive immune resistance

Paul C. Tumeh et al.

NATURE (2014)

Article Cell Biology

TREM-2 (triggering receptor expressed on myeloid cells 2) is a phagocytic receptor for bacteria

Elsa-Noah N'Diaye et al.

JOURNAL OF CELL BIOLOGY (2009)

Review Immunology

Perspective on antigen processing and presentation

ER Unanue

IMMUNOLOGICAL REVIEWS (2002)